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In this study, we describe the identification of nine novel genes isolated from a unique human first-trimester cDNA library generated from
the placental bed. One of these clones, called C2360 and located on chromosome 10q22, was selected as it showed restricted expression in
placental bed tissue as well as in JEG3 choriocarcinoma cells with absent expression in adult tissues. We show that the expression is restricted
to first-trimester proliferative trophoblasts of the proximal column and show that C2360 is a nuclear protein. No detectable transactivation
potential was observed for different domains of the protein. Secondary structure prediction showed that C2360 is a representative member of
a eukaryotic family of proteins with a low conservation at the amino acid level, but with strong conservation at the structural level, sharing
the general domain (coiled coil 1)–(helix 1)–(coiled coil 2)–(helix 2), or CHCH domain. Each a-helix within this domain contains two
cysteine amino acids, and these intrahelical cysteines are separated by nine amino acids (C-X9-C motif). The fixed position within each helix
indicated that both helices could form a hairpin structure stabilized by two interhelical disulfide bonds. Other proteins belonging to the family
include estrogen-induced gene 2 and the ethanol-induced 6 protein. The conserved motif was found in yeast, plant, Drosophila,
Caenorhabditis elegans, mouse, and human proteins, indicating that the ancestor of this protein family is of eukaryotic origin. These results
indicate that C2360 is a representative member of a multifamily of proteins, sharing a protein domain that is conserved in eukaryotes.
D 2003 Elsevier Inc. All rights reserved.Keywords: C2360; Extravillous trophoblast; CHCH domain; Nuclear protein; Proliferation; Placental bed
From gene targeting experiments, several genes that are However, systematic studies of this kind have been doneessential for placental development and function have been
identified [1,2]. Recently, as a consequence of cDNA micro-
array technology, systematic approaches of large-scale ge-
nome-wide gene expression analysis have been performed in
mouse placental tissues with unexpected results. Specific
gene classes [3] as well as new genes [4–6] not detected
previously by conventional means were identified. This sets
the stage for systematic exploration and monitoring of tran-
scriptome changes during placental development, particular-
ly related to placental dysfunction-related disorders.0888-7543/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2003.12.006
$ Sequence data from this article have been deposited with the EMBL/
GenBank Data Libraries under Accession No. LOC118487.
$$ Supplementary data for this article may be found on ScienceDirect.
* Corresponding author. Fax: +31-20-4443895.
E-mail address: cbm.oudejans@vumc.nl (C.B.M. Oudejans).only for mouse placental development. Applications to
human development are hampered by the lack of appropriate
tissue samples, particularly for early developmental stages.
This is certainly the case for human tissue samples repre-
sentative of the first-trimester placental bed containing the
extravillous trophoblast cells invading the deeper layers of
the maternal myometrium of the uterus. Invasion of these
cells shares features with invasive and metastatic tumor cells.
A number of regulators have been described as involved
in the processes occurring at the proliferative/invasive
transition zone during first-trimester human extravillous
trophoblast differentiation. We constructed a unique cDNA
library of human placental bed tissue enriched for first-
trimester extravillous trophoblasts in various stages of
invasion, containing 13,000 clones, and searched for factors
that regulate or reflect the processes involved during human
Fig. 1. RT-PCR expression profile of nine genes of the placental bed cDNA library shows that C2360 is strongly expressed in the first-trimester placenta and in the choriocarcinoma cell line JEG3. Weak expression
of C2360 is restricted to early development tissues, as observed in embryonic brain, fibroblasts cultured from chorionic villus sample Vc992, and full-term placenta. RT-PCRs are shown on the left and PCR control
reactions on the right within each column. All genes are expressed in the first-trimester placenta, except for C2026. Expression analysis of GAPDH was used as an input control.
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B.A. Westerman et al. / Genomics 83 (2004) 1094–11041096placenta development. Here, we report the cloning and
identification of a gene called C2360 (LOC118487) that
showed strong, nuclear expression in proliferative cytotro-
phoblasts of the first trimester placenta and which contains a
novel protein domain that is representative of a large family
of proteins with a conserved structure.Results
Identification of nine transcribed chromosomal sequences
with unknown organization and function
To identify genes expressed during placental develop-
ment and in particular during the process of invasion by
extravillous human trophoblast cells migrating into the
decidual and myometrial parts of the maternal uterus, pla-
cental bed tissue at the gestational age of 10 weeks contain-
ing all stages of trophoblast invasion was used to construct a
cDNA library. Of 268 screened cDNA sequences, nine
clones were present that had open reading frames that either
did not correspond to known proteins or did not show
homology to known proteins. RT-PCR was performed to
determine the mRNA expression profile of each of theseFig. 2. Nucleotide and amino acid sequences of human C2360. The nucleotide an
sequence. The location of the predicted (coiled coil 1)– (helix 1)– (coiled coil 2)– (
two cysteine amino acids at fixed positions within each helix are highlighted. Th
codons are shown in boldface. The sequence is available under GenBank Accessgenes in various tissues, including adult tissues. These
results are shown in Fig. 1. Most genes show a broad
expression in all tissues. However, one gene, C2360, showed
a strong and tissue-restricted expression, with strongest
expression observed in the first-trimester placental bed and
in the choriocarcinoma cell line JEG3. There were weak
bands seen in other developmental tissues, i.e., embryonic
brain, chorionic villus fibroblasts, and full-term placenta.
The adult tissues heart, pancreas, adrenal gland, kidney,
liver, and lung did not show expression of C2360 mRNA.
The gene structure of C2360 showed that C2360 is a
triple-exon gene. To determine the 5V end of the C2360
transcript, the Image clones 2583-g16, 3779-g19, CM1201-
g06, 10105-j23, and 10720-j15 were sequenced. The se-
quence of the protein-encoding region is given in Fig. 2.
When these experiments were in progress, the gene was
annotated by the NCBI under Accession No. LOC118487.
Three-dimensional position-specific scoring matrix
(3D-PSSM) analysis shows that C2360 contains a double
helical protein motif
Because standard BLAST and Prosite analysis of the
C2360 protein did not show homology or the presence ofd deduced amino acid sequence numbering is shown on the left side of the
helix 2) domain is shown by black (coiled coil) and gray (helix) boxes. The
ree putative phosphorylation sites are indicated in italic. The start and stop
ion No. LOC118487.
B.A. Westerman et al. / Genomics 83 (2004) 1094–1104 1097conserved domains on the primary amino acid sequence
level, the amino acid sequence was analyzed with the 3D-
PSSM program. This fold-prediction algorithm predicts the
structural folding of the protein and compares them to a
representative set of structurally known protein families. This
methodology allows detection of proteins or protein domains
that share very little sequence similarity by aligning them
with sequence profiles that are representative of the diversity
of a given multifamily [9]. The protein did not show overt
homology to the protein families present in the database.
The secondary structure analysis of the 3D-PSSM pro-
gram predicted the presence of two centrally located a-
helical domains separated by a coiled coil domain. Within
both helices, two cysteines were identified, each separated
by nine amino acids (Fig. 2). This pointed toward a
structural conservation, suggesting the presence of a disul-
fide bond between both helices, which could stabilize a
hairpin domain when the helix 2 folds onto helix 1.  
Fig. 3. Alignment of conserved protein domains that have a secondary structure
consensus sequence is given at the top. The secondary structure is given below
domain regions (H) are shown in blue, extended sheets (E) are shown in yellow, an
amino acids glutamic acid (E), at position 6, and phenylalanine (F), at position 10,
the secondary structure and grouped into the subgroups S, N, and C (see Discussion
proteins belonging to the DUF657 group are indicated by asterisks (*).Alternatively, the four cysteines could act as ligands of a
metal-binding domain, similar to the domains observed in
zinc-finger and related proteins [10].
C2360 is a member of an a-helical protein multifamily
Additional 3D-PSSM structural analysis was therefore
performed on weakly similar amino acid sequences from
various eukaryotic species. This showed that this structural
domain was present in a large number of other proteins,
indicating a conserved and potentially important function.
An alignment of these related proteins with the predicted
conserved domain is given in Fig. 3. Note that each protein
contains the conserved cysteines located in both predicted
helix regions and each cysteine pair is separated by nine
amino acids (C-X9-C motif). Within each helix, a high
occurrence of glutamic acid (E) at position 6 and phenylal-
anine (F) at position 10 was seen.  
similar to the C2360 protein as predicted by the 3D-PSSM program. The
each amino acid sequence. Coiled coil regions (C) are shown in red, helix
d conserved cysteine residues (C) are shown in green. The highly occurring
within each helix are shown in yellow. Proteins were classified according to
for details). The N group overlaps with the DUF657 PFAM domain and the
Fig. 4. (A and B) RNA in situ hybridization using C2360 antisense-Dig riboprobes showing that C2360 mRNA is expressed in cytotrophoblasts of the proximal
column. (C) Immunostaining with the MIB1 antibody shows that C2360 is expressed in cells that express the proliferation marker Ki67. (D) Immunostaining
for HLA-G, a marker of differentiated extravillous trophoblasts, is negative in these proliferative cytotrophoblasts. The inset shows the results of a positive
control HLA-G immunostaining.
B.A. Westerman et al. / Genomics 83 (2004) 1094–11041098In addition, two coiled coil regions were predicted. The
first coiled coil region, which has a fixed length of 10 amino
acids, is located N terminal of helix 1. The second coiled coil
is present between both helices and possibly acts as a bridge
when the helices fold toward each other. This coiled coil
region has a variable length of 5 to 10 amino acids. Together
these domains form a (coiled coil 1)–(helix 1)–(coiled coil
2)–(helix 2) domain or CHCH domain. Note that most but
not all proteins showed the presence of coiled coil 1.Fig. 5. Transfection of JEG3 with GFP fusion protein constructs showing the intra
(indicated on the right) show (B) a nuclear localization for the wild-type protein as
form and (A) GFP show a cytoplasmic localization, showing that the nuclear locThe human and mouse C2360 amino acid sequences
show 85% identity in the conserved domain. In Drosophila
as well as Caenorhabditis elegans, proteins with a remote
homology to C2360 were observed. The conserved domain
of the Drosophila CG12848-PA protein has 46% identity to
the human protein and the C. elegans 4F924 protein has
30% identity compared to the human conserved domain. It
is yet unclear if these proteins are orthologs. Taken together,
these 3D-PSSM data indicate that C2360 belongs to a groupcellular localization of the C2360 protein. The C2360 truncation constructs
well as (D) the C-terminally truncated form. (C) The N-terminally truncated
alization domain of C2360 resides in the N-terminus of the protein.
B.A. Westerman et al. / Genomof proteins that have a conserved CHCH structural back-
bone with each helix containing a C-X9-C cysteine pair.
C2360 is expressed in proliferative cytotrophoblasts at the
proximal zone
RNA in situ hybridization analysis was performed to
analyze the in situ localization of C2360 mRNA in the first
trimester placental bed. This showed that the expression was
restricted to proliferative cytotrophoblast at the proximal
zone of the placental anchoring villi (Fig. 4). Differentiated
trophoblasts, both villous and extravillous, showed no
expression. There was no expression observed in prolifera-
tive cytotrophoblasts located inside the villi, suggesting that
C2360 is expressed in a specific subset of proliferative
trophoblast cells at the junctional zone of villus to extra-
villus transition.
Intracellular localization experiments showed that C2360 is
a nuclear factor
Truncation constructs of the C2360-encoding region
fused to eGFP were used to determine the intracellular
localization of the protein. The wild-type GFP-C2360WT
fusion protein shows a clear nuclear localization (Fig. 5).
When the C-terminal region was truncated (C2360DC1),
this fusion protein also showed a nuclear localization,
indicating that the nuclear translocation region resides in
the conserved motif or in the N-terminal region. Indeed,
when the N-terminal region was truncated (C2360DN1), the
fusion protein showed a cytoplasmic localization, indicating
a putative nuclear localization signal or interacting domain
in the N-terminal part of the protein. These results clearly
show that C2360 is a nuclear protein with an N-terminally
located nuclear localization domain.Fig. 6. Transfections of JEG3 cells with C2360-GAL4 DNA binding domain (DBD
detectable transactivation activity in this assay. The principle is shown in (C) (see
control experiments show a clear CAT activity.C2360 shows no detectable transactivation
The nuclear localization indicated that C2360 could be a
transcription factor. We analyzed the transactivation poten-
tial of the protein by fusing the protein to a DNA-binding
protein that recognizes the GAL4 motifs present in a
reporter vector. When a transactivation domain is present
on the fused protein, this will result in an increase in the
basal promoter activity of the reporter vector (principle
shown in Fig. 6C). Several truncation constructs (Fig. 6B)
were tested for transactivation potential (Fig. 6A) and,
although the positive control constructs showed a clear
response, no detectable response was observed in the
C2360 truncated proteins.
ics 83 (2004) 1094–1104 1099Discussion
We have identified C2360 as a nuclear protein that is
expressed in proliferative extravillous trophoblast cells of
the first-trimester placenta. The small nucleoprotein of 118
aa located on human chromosome 10 has a conserved
rodent homolog, and proteins with a remote homology were
seen in Drosophila and C. elegans. Based on secondary
structure analysis we show that the C2360 protein is a
member of a family of proteins with a low conservation at
the amino acid level, but with strong conservation at the
structural level with the general domain: (coiled coil 1)–
(helix 1)–(coiled coil 2)–(helix 2). This domain is called a
CHCH domain. The ancestor of this protein family is likely
to be of eukaryotic origin as no homologs have been
observed in prokaryotes.
Within this group of proteins containing the CHCH
domain, a classification was made based on the results of
the secondary structure analysis. This resulted in the defi-) fusion protein constructs, showing that the C2360 protein does not have a
also Results). The transactivation constructs are shown in (B). (A) Positive
Fig. 7. Model of the predicted structure of the S group of proteins
containing the conserved CHCH domain as predicted using the 3D-PSSM
program. The backbone consists of a 10-amino-acid coiled coil region,
followed by two 15-amino-acid a-helices connected by a coiled coil region
of 5 to 10 amino acids. Based on the structure of the p8MTCP1 protein [12–
14], the two a-helices are expected to form a hairpin– loop that is stabilized
by two disulfide bonds, which are formed by two cysteine pairs that have a
fixed position within each helix. Each of these cysteines is separated by 9
amino acids. The highly occurring amino acids glutamic acid (E) and
phenylalanine (F) have fixed positions within both helices and reside
between both helices in this predicted structure. The two domains flanking
the conserved region have a relatively undefined predicted structure, based
on 3D-PSSM structure prediction and NMR data in the case of the p8MTCP1
protein [12].
B.A. Westerman et al. / Genomics 83 (2004) 1094–11041100nition of three subgroups, the small proteins group, the N-
extended group, and the C-extended group, and these are
referred to as S, N, and C in Fig. 3.
The S group represents a group of proteins with a small
size of 71–164 residues and these proteins have a centrally
located CHCH domain. This group of proteins includes
C2360, Mrp10p, estrogen-induced gene 2 (E2IG2) and
mature T-cell proliferation-1 type A (p8MTCP1).
The N group has an extended N-terminal amino acid
region compared to the S group and the conserved CHCH
domain is located close to the C-terminus. This group
includes the ethanol-induced protein 6 and includes homo-
logs of Etohi6, which were grouped into a protein domain
designated DUF657 in the Protein Family database (PFAM;
Sanger Institute). The PFAM domain contains, in addition to
the C-X9-C motif, an additional GXXXGH motif, located
N-terminal of the CHCH domain.
The last group, the C group, has a different conserved
domain, although it has a structural overlap with the S
and N groups. First, these proteins have a second double-
helix motif, located C-terminal of the conserved double-
helix motif. This motif also contains cysteine pairs in
each of both a-helices. Second, these proteins lack the
predicted N-terminal coiled coil region or have a small
coiled coil region. Third, the conserved motif is found close
to or at the N-terminus. This distinct group of proteins
includes NADH-ubiquinone oxidoreductase subunit proteins
[11].
Both helices in the CHCH domain contain a cysteine pair,
and the presence of cysteines at conserved positions within
the helices suggests that disulfide bonds connect both helices.
Indeed, the p8MTCP1 protein has been investigated by NMR
structure analysis and the two helices of the p8MTCP1 protein
were shown to be covalently linked by two disulfide bonds,
forming an a-hairpin, resembling an antiparallel coiled coil
[12–14]. The p8MTCP1 protein is classified into the S group in
our classification and the other proteins present in this group
are expected to have a similar structure. This indicates that the
presence of the putative metal binding of the four cysteines as
suggested under Results is less likely. A schematic model of
this proposed three-dimensional structure is given in Fig. 7.
The C group of proteins is expected to have another three-
dimensional structure due to the presence of the second
double-helix motif.
Our data indicate that C2360 is a protein that is expressed
strongly during early extraembryonic development, as
shown for the first-trimester placenta and JEG3 choriocar-
cinoma cells. Other tissues of early developmental stages,
including embryonic brain and extraembryonic fibroblasts
cultured from chorionic villus samplings, showed weak
bands in the RT-PCR, indicating lower levels of expression.
In addition, C2360 is expressed in human embryonic stem
cells as well (results not shown). In contrast, all adult tissues
screened showed no detectable expression of the transcript.
Two other CHCH proteins, E2IG2 [15] and Etohi6 [16]
have been described to respond to estrogen and ethanol,respectively. We tested if estrogen or ethanol induced C2360
transcription; however, no significant upregulation was
observed (results not shown).
In Drosophila, the l(3)03670 gene (also called l[3]96601
or CG1715-PA) encodes a protein that is classified as an N-
group protein in our classification [17]. This protein showed a
broad expression in the embryo with a slightly higher
expression in the head. A P-element-introduced homozygous
deletion of this gene, l[3]03670, gave a lethal phenotype. The
lethal phenotype could be reversed by excision of the P
element [17]. This gene has homologs in humans and mouse
(Accession Nos. NP_060282, NP_115719 and AAH16528,
BAB24193, NP_079627, respectively). The C. elegans ho-
molog of this gene, called M176.3 (Accession No.
NP_496012), showed a 42% lethality in RNAi experiments
of Maeda and co-workers [18] and a wild-type phenotype in
RNAi experiments of Kamath and co-workers [19]. Although
there might be some variation in penetrance, these results
could indicate that this member of the CHCH family is
involved in the progression of developmental processes.
An important question is if the CHCH motif represents a
functional domain in these proteins. In the p8MTCP1 protein,
the conserved motif consists of 40 amino acids, while the
total protein size is 71 amino acids, showing that the
conserved domain represents the majority of the protein.
The high occurrence of glutamic acid (E) at position 6 and of
phenylalanine (F) at position 10, each located at fixed
positions within each a-helix, might indicate that there are
functional or structural constraints on the presence of these
B.A. Westerman et al. / Genomamino acids. The intracellular localization of CHCH proteins
shows variations as were shown for p8MTCP1 (c6.1B) and
Mrp10p [20], which have been described as localized to the
mitochondria in contrast to C2360. The p8MTCP1 protein is a
putative oncogene that is expressed in T cell prolymphocytic
leukemia with t(X;14) translocations [21,22]. The Mrp10p
protein has been described as a mitochondrial ribosomal
protein, since it was shown to be associated with a small
ribosomal unit when sedimented by centrifugation, suggest-
ing that Mrp10p is associated with the translational machin-
ery [20]. Based on the intracellular localization, these data
could suggest that the functions of CHCH proteins are
divergent. We could not detect transactivation potential for
the C2360 protein. However, these results do not rule out the
possibility that the protein could act as a transactivator or as a
transcriptional repressor. It is a challenge for the future to
determine the function of C2360 as well as the other
members of this novel CHCH family.Experimental procedures
Cell culture and tissues
First-trimester human placental tissue fragments (weeks
6–10 gestational age) (n = 11) were obtained by the
Department of Pathology, Section of Human Reproductive
Immunology, University of Cambridge from pregnancy
terminations. Adult tissues were obtained by the Department
of Pathology at the VU University Medical Center (VUMC).
The hysterectomy specimen was obtained by E.A.P.S. Term
placenta tissues were obtained by the Department of Gyne-
cology of the VUMC. The Department of Cytogenetics of
the VUMC obtained chorionic villus samples, used to culture
fibroblasts of extraembryonic origin. Tissues were stored
frozen at 70jC or in liquid nitrogen. Fibroblasts were
maintained in Amniomax medium including supplements
(Life Technologies). The choriocarcinoma JEG3 cell line
was maintained in Iscove’s medium with Glutamax I (Life
Technologies) supplemented with 10% FBS and antibiotics.Table 1
Primers used for the RT-PCR expression profile
Clone Forward primera
1786 5V-CCATCCAGCAGAGCCTGCTT-3V
1878 5V-CAGCCCGTCTTCCGGAATTTCTCAAC-3V
1883 5V-CCTGAGCAAATTCATGATGTTGTACG-3V
1897 5V-GCCAAGAATTTCTCTCACTTAAGCAGGA-3V
1961 5V-CCCTCCCCTTTGGTGTGA-3V
2026 5V-CAAGGCCTTCGAGTGTAA-3V
2321 5V-CCGTGCAAATGCCAAAGT-3V
2360 5V-CGCGACGATGCGTGCAGA-3V
2426 5V-AGGGCTCTCCGAGCCACGTACC-3V
GAPDH 5V-CGGAGTCAACGGATTTGGTCGTAT-3V
a Each forward primer was chosen in the sense strand.Identification of genes
A previously prepared cDNA library of placental bed
tissue from the decidua–myometrium transition zone of a
hysterectomy specimen at a gestational age of 10 weeks
diagnosed for cervical carcinoma [7] was used to identify
novel genes. Sequencing was performed using an ABI 310
genetic analyzer (Perkin–Elmer) using the Big Dye-M13
forward primer for sequencing of plasmid DNA or Big
Dye terminator reactions in combination with gene-specific
primers for sequencing of Qiagen-purified PCR products.
From the library, we selected nine genes that either were
not annotated in cDNA libraries of HUGO/Celera data-
bases or could not be classified according to their homol-
ogy with proteins with known function. To determine the 5V
end of the selected C2360 transcript, Image clones (2583-
g16, 3779-g19, CM1201-g06, 10105-j23, and 10720-j15)
were sequenced.
mRNA expression profile by RT-PCR
The nine selected clones were analyzed for gene struc-
ture using the NIX analysis method of HGMP and, based
on this analysis, primers were designed (Table 1). Expres-
sion analysis of the nine selected genes was performed by
RT-PCR using the Superscript II (RNase H negative) One-
Step RT-PCR System (Invitrogen). One microgram of total
RNA was mixed with forward and reverse primers (50
pmol each) in a total volume of 10 Al and heated for 1 min
at 95jC, followed by immediate cooling on ice. RT-PCR
buffer including dNTPs, magnesium sulfate (1.25 mM),
betaine (1 M), 7.5 units RNasin (Promega), and 1
Al enzyme mix were added to a total volume of 50 Al.
RT-PCR mixes were subjected to reverse transcription for
30 min at 50 or 55jC (dependent on the GC content of the
template), followed by inactivation of RT enzyme at 95jC
(1 min) and PCR consisting of 35 cycles (denaturation, 1
min at 95jC; annealing at an appropriate temperature;
extension, 2 min at 72jC) with a final extension at 72jC
for 10 min.
ics 83 (2004) 1094–1104 1101Reverse primer Product size
5V-CCCCAAGCTCAGCAGCAGAG-3V 433 bp
5V-CCAGTACATGCAAGGTAAAAACTTGACG-3V 216
5V-GGGCAGGATTGGGGTGTTCA-3V 268
5V-AGGCTTTTCCCTAAAGGCCTCTA-3V 183
5V-CCCTGGCTTGGACCCTTA-3V 103
5V-TCTGCCACTTGGGATTTG-3V 119
5V-GGCACAGGTTGCCAAGAG-3V 261
5V-GGGCATGGCAATGCCAATG-3V 263
5V-TCGGGCGGCTAACAGAGGTAGC-3V 307
5V-AGCCTTCTCCATGGTGGTGAAGAC-3V
Table 2
Primers used for the truncation constructs used in the intracellular localization determination and to identify transactivation domains of C2360
The primers are based on sequence BC020852. Primer pairs 1, 3, and 5 were used to clone truncated fragments of C2360 cDNA into the pEGFP-C2 vector.
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enomics 83 (2004) 1094–1104 1103Localization of mRNA expression of C2360 by RNA in situ
hybridization
Localization of C2360 mRNA expression in the placental
bed was done by RNA in situ hybridization. C2360 cRNA
riboprobes were generated by in vitro transcription of a 441-
bp cDNA fragment, which was amplified with the primers
forward-BglII, 5V-GTCCGGACTCAGATCTATGGCGA-
CACCCAGCCTG-3V, and reverse-PstI, 5V-GTACCGTC-
GACTGCAGGGCATGGCAATGCCAATG-3 V, and
subsequently cloned into a pGEMT vector (Promega). Anti-
sense cRNA probes were made by linearizing with NcoI and
transcribing with SP6 RNA polymerase (Promega). Sense
cRNA probes were made by linearizing with NotI and tran-
scribing with T7 RNA polymerase, both in the presence of
25% DIG-11–UTP.
Cryostat sections were air dried at room temperature and
fixed for 20 min in freshly prepared 4% paraformaldehyde in
phosphate-buffered saline (PBS; 0.9 mM Na2HPO4, 0.17
mMNaH2PO4, 150 mMNaCl, pH 7.4), rinsed three times for
5 min each in PBS, and rinsed briefly in water. After
acetylation for 10 min with 0.25% acetic anhydride in 1%
triethanolamine and two washing steps in PBS, sections were
rinsed in 2 standard saline citrate (20 SSC: 3 M NaCl,
1.55 M sodium citrate, pH 7.0) for at least 5 min. The slides
were prehybridized for 4 h at room temperature in hybrid-
ization buffer containing 50% formamide, 10% dextran
sulfate, 1 Denhardt’s solution (50 Denhardt’s: 0.5 g
Ficoll, 0.5 g polyvinylpyrrolidone, 0.5 g bovine serum
albumin in 50 ml MilliQ water), 0.2 SSC, 500 Ag/ml
denatured salmon sperm DNA (Roche), and 250 Ag/ml tRNA
(Sigma). Hybridization was performed using denatured
C2360 cRNA riboprobes diluted 1:500 in hybridization
buffer, covered with Parafilm, and incubated overnight in a
moist chamber at 55jC. The following day the sections were
washed with 5 SSC for 5 min, rinsed in 2 SSC, and
washed under high stringency in 0.2 SSC in 50% formam-
ide for 30 min (all at 55jC), followed by a final wash with
0.2 SSC for 5min at room temperature. Immunohistochem-
ical detection of immobilized DIG riboprobes was then
performed. For this, sections were washed in digoxigenin
buffer (DB) (33 mM maleic acid, 50 mM NaCl, pH 7.5) (5
min) and blocking solution was added for 1 h at room
temperature (1% w/v Blocking reagent (Roche) in DB).
Anti-DIG–alkaline phosphatase antibody (Roche; 1:5000
dilution in DB) was added after blocking and the sections
were incubated for 1.5 h at room temperature. Sections were
washed in DB (2  15 min) and then washed in digoxigenin
detection buffer (DDB) (33 mM Tris, 33 mM NaCl, 50 mM
MgCl2, pH 9.5) for 5 min. The alkaline phosphatase color
reaction was performed using 45 Al (75 mg/ml) nitroblue
tetrazolium, 35 Al (50 mg/ml) bromo-4-chloro-3-indolyl
phosphate, and 2.4 mg freshly added levamisole in 10 ml
DDB. Sections were incubated (1–4 h) in the dark in a
humidified box. The color reaction was terminated by wash-
ing in TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) (5 min)
B.A. Westerman et al. / Gfollowed by mounting in Depex. Nonspecific hybridization
was examined using slides that had been incubated with sense
probe.
Determination of the intracellular localization and
transactivation potential of C2360
Intracellular localization and transactivation potential
were determined by visualization of eGFP–C2360 fusion
proteins and by a mammalian two-hybrid assay, respectively.
Truncated cDNA fragments of C2360 were cloned down-
stream of the eGFP coding region of the pEGFP-C2 (Clon-
tech) or cloned downstream of the Gal4 DNA binding domain
(GAL4-DBD)-encoding region into the pM vector of the
Mammalian Matchmaker Two-Hybrid Assay Kit (Clontech).
Primers are listed in Table 2. Plasmidswere purified by anion-
exchange chromatography (Qiagen).
SGHPL5 cells [8] were transfected with the plasmids
using Fugene 6 (Roche) according to the manufacturer’s
instructions. Expression analysis was performed 24 h after
transfection (GFP) or 72 h after transfection (CAT assay).
Intracellular localization of the GFP fusion proteins was
performed by fixation of the cells in 4% paraformaldehyde
in PBS, nuclear staining with Hoechst 33342 (1 Ag/ml), and
subsequent fluorescence microscopy using a triple band-
pass filter. The presence of a transactivation domain on
C2360 was measured (in triplicate) by cotransfection of the
pM constructs with a pG5CAT reporter vector, containing a
GAL4 promoter fragment upstream of the CAT enzyme.
The CAT activity was measured using the CAT-ELISA kit
(Roche). CAT levels were normalized using the total
protein content of each sample. Positive controls were
pM53, PVP16-T (p53 versus SV40 large T antigen pro-
tein–protein interaction), and pM3-VP16 (fusion protein of
GAL4-DBD with the herpes simplex VP16 protein, which
contains an activation domain). Negative controls were
pM53, PVP16-CP (p53 versus polyomavirus coat protein
interaction), and pM, PVP16-T (empty pM vector versus
SV40 large T antigen interaction).
Computer structure analysis
Secondary structure analysis was performed using the
3D-PSSM protein fold prediction program [9] to detect
remote homology relationships between an uncharacterized
protein sequence and proteins with known structures.Acknowledgments
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